Compare Delta Air Lines, Inc. (DAL) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Delta Air Lines, Inc. vs Medpace Holdings Inc — how do they compare? Delta Air Lines, Inc. trades at $90.38 (market cap $59.46B), while Medpace Holdings Inc trades at $609.54 (market cap $16.90B). The key difference: Delta Air Lines, Inc. is far larger — about 3.5× Medpace Holdings Inc's market cap, and Delta Air Lines, Inc. pays a 0.86% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| DAL | MEDP | |
|---|---|---|
Market Cap | $59.46B | $16.90B |
Sector | Industrials | Technology |
52-Week High | $93.66 | $620.59 |
52-Week Low | $55.65 | $393.42 |
Enterprise Value | $74.77B | $16.52B |
Dividend Yield | 0.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Delta Air Lines, Inc.
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.
Read more on DAL →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
